BCIC生態 ｜ BCIC 獲獎團隊 Affinity Biopharma 完成 4 億元人民幣 B2 輪融資
祝賀 Affinity Biopharma 成功完成 4 億元人民幣（約 6,000 萬美元）B2 輪融資。Affinity Biopharma 在由 Boston Chinese Investment Club (BCIC) 與 Hong Kong Science and Technology Parks Corporation (HKSTP) 聯合主辦的 2024 Biomedical Pitch Competition 中榮獲二等獎。
http://www.affinitybiopharma.com/en/newsD-543.html
2024 Biomedical Pitch Competition 決賽獲獎名單
一等獎
GV20 Therapeutics
二等獎
Affinity Biopharma
Axcynsis Therapeutics
三等獎
ImmVira Group: A Novel Payload Delivery
Rapafusyn Pharmaceuticals
Cure Genetics Inc.
D2M Biotherapeutics
Innovation Award
Leveragen, Inc.
f5 Therapeutics Incorporated
Agilis Robotics Limited
Spark Spine
Azura Bio, Inc.
AI-powered Painless Blood Test Device
NeuronOff, Inc.